Scientific deep-dive

The Low-FODMAP Diet on a GLP-1: What It Does for IBS and What Is Untested

The low-FODMAP diet has the strongest trial record of any IBS diet, but it was never designed to cause weight loss, and no trial has tested it on Ozempic, Wegovy, Mounjaro or Zepbound side effects. Food swaps, the three phases, and the fiber and eating risks on a GLP-1.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
11 min read·29 citations

Part of Weight-loss supplements and diet trends: what the trials show

The low-FODMAP diet is a short elimination diet for irritable bowel syndrome, and for that job it has the strongest trial record of any diet: across 24 randomized trials it cut the chance that IBS symptoms failed to improve by about half compared with a usual diet.[1] It is not a weight-loss diet. No trial has tested it on the bloating, gas or diarrhea that Ozempic, Wegovy, Mounjaro or Zepbound cause, so whether it helps on a GLP‑1 is unknown. What is known is that its restriction phase cuts fiber and variety at a time when the drug is already cutting how much you eat.

About this article. Written from the randomized trials and meta-analyses of the low-FODMAP diet, the American College of Gastroenterology and American Gastroenterological Association guidance, food-composition studies from the Monash University group that developed the diet, the NIH’s digestive disease institute, and the current Wegovy and Zepbound labels on DailyMed. Nothing here is a reason to start, stop or change a medicine. If you had IBS before starting a GLP‑1, the GLP-1s with IBS, IBD or gastroparesis questions cover the drug side.

What FODMAPs are

The acronym packs in five words. F is for fermentable; O, D and M are the oligo-, di- and monosaccharides; A is simply “and”; P is for polyols. All are short-chain carbohydrates that the small intestine absorbs poorly. In practice that means fructans (wheat, rye, onion, garlic), galacto-oligosaccharides or GOS (beans and lentils), lactose (milk), fructose in excess of glucose (apples, pears, honey) and sugar alcohols such as sorbitol and mannitol.[3] They are not unhealthy. Many of them feed gut bacteria, which is part of the problem for people with a sensitive gut.

They cause symptoms in two ways. Some pull water into the small bowel; others reach the colon intact, where bacteria ferment them into gas.[3] An MRI study in healthy volunteers showed both: a fructose drink swelled the small bowel with water, while inulin, a fructan, filled the colon with gas.[4] When people with IBS ate a high-FODMAP diet for two days, their breath hydrogen, a marker of fermentation, was about four times higher than on a low-FODMAP diet (242 against 62 ppm across 14 hours), and their symptoms flared.[5] Healthy volunteers produced the gas too, but mostly noticed only more wind. The diet works by lowering the load on a gut that overreacts to it.

What the trials show in IBS

The first well-controlled test fed 30 people with IBS either a low-FODMAP diet or a typical Australian diet for three weeks each, with almost all food provided. Overall symptom scores were 22.8 on the low-FODMAP diet against 44.9 on the typical diet, on a 100-point scale, and bloating, pain and wind all fell.[6] Many trials have followed. The largest pooled analysis, from 2025, covered 28 randomized trials of 11 different diets in 2,338 people.[1]

Low-FODMAP diet against a habitual diet in IBS: 2025 network meta-analysis. A relative risk below 1 means fewer people whose symptoms did not improve.
OutcomeTrialsRelative risk of not improvingWhat it means
Global IBS symptoms240.51 (0.37–0.70)About half the risk of no improvement
Abdominal pain230.61 (0.42–0.89)Fewer people left with unimproved pain
Bloating or distension230.55 (0.37–0.80)The only repeatedly tested diet that beat a habitual diet
Bowel habit23 (all diets)No diet beat any controlNot a reliable fix for diarrhea or constipation

The reviewers rated the direct comparison against a habitual diet as moderate confidence and concluded that the most evidence exists for the low-FODMAP diet.[1] A diet cutting starch and sucrose ranked higher for global symptoms, but on only two trials. An earlier network analysis of 13 trials ranked the low-FODMAP diet first on every outcome, while noting that most trials ran in specialist clinics and few tested the reintroduction phase that the diet depends on.[2]

The weaker spot is the comparison with ordinary IBS advice: regular meals, smaller portions, less fat, caffeine and gassy food. In a Swedish trial of 75 people, half the low-FODMAP group and 46% of the traditional-advice group had a meaningful drop in symptoms, a difference that could be chance.[7] In a US trial of 92 people with diarrhea-predominant IBS, 52% on low FODMAP and 41% on modified standard advice reported adequate relief, again not a significant gap, although pain and bloating fell further on the low-FODMAP diet.[8] The American College of Gastroenterology recommends “a limited trial” of the diet for global IBS symptoms.[9] The American Gastroenterological Association calls it the most evidence-based diet for IBS and says simpler healthy-eating advice helps some patients too.[10]

Low-FODMAP foods: common swaps

The swaps below come from the Monash University food list, the NIH’s IBS diet page and Monash’s laboratory measurements.[11][12] The richest fructan sources in a test of 60 vegetables were garlic, artichoke, shallots, leek bulb and onion, at 1.2 to 17.4 g per 100 g.[13] Among grain foods, a portion of rice held no fructan, oats 0.11 g and dark rye bread 0.6 g, while GOS turned up mainly in pulses.[14] Serving size matters: many foods are low at a small portion and high at a large one, which is why Monash keeps its full ratings in an app rather than a list.[11]

Examples of high-FODMAP foods and lower-FODMAP alternatives. Sources: Monash University FODMAP food list and NIDDK.
Food groupHigh in FODMAPsLower-FODMAP swapsMain FODMAP
VegetablesOnion, garlic, leek, artichoke, asparagus, mushrooms, green peasCarrot, cucumber, lettuce, potato, eggplant, green beans, bok choyFructans; mannitol in mushrooms
FruitApples, pears, mango, cherries, watermelon, peaches, plums, dried fruitOrange, mandarin, kiwifruit, pineapple, blueberries, cantaloupeExcess fructose, sorbitol
DairyCow's milk, yogurt, ice cream, custard, soft cheesesLactose-free milk, hard cheeses, feta, brie, butterLactose
Plant milksSoy milk made from whole soybeansAlmond milk, rice milk, soy milk made from soy protein (calcium-fortified)GOS
ProteinMost beans and lentils, marinated or processed meats, sausagesEggs, firm tofu, tempeh, plain meat, poultry and fishGOS; garlic and onion in marinades
GrainsWheat, rye and barley breads, cereals and pastaOats, rice, quinoa, corn or rice pasta, sourdough spelt breadFructans
SweetenersHoney, high-fructose corn syrup, sugar-free gum and candyTable sugar, maple syrup, dark chocolateFructose; sorbitol, mannitol, xylitol, maltitol
NutsCashews, pistachiosPeanuts, macadamias, walnuts, pumpkin seedsGOS, fructans

Two details matter for anyone on a GLP‑1. Plain meat, poultry, fish and eggs are naturally free of FODMAPs, so the diet does not get in the way of a protein target.[11] And the high column is where much of the fiber lives: wholegrain wheat and rye, beans and lentils, and several fruits.

The three phases

The diet is not meant to be followed for good. Both the gastroenterology association and the Monash group describe three steps.[10][15]

  1. Restriction. Swap high-FODMAP foods for low ones for two to six weeks, by Monash’s timing, and no longer than four to six weeks by the AGA’s.[10][15] If symptoms have not improved by then, the AGA says to drop the diet and try something else.[10]
  2. Reintroduction. Test one FODMAP group at a time. Monash’s method is a food rich in a single FODMAP, eaten daily for three days, while symptoms are recorded.[15] In a blinded US trial of 21 people who had responded to restriction, fructans and GOS were the groups linked to more pain, and GOS to more bloating; the other groups were tolerated better.[16]
  3. Personalization. Bring back everything that was tolerated and limit only the triggers, and only as far as needed for relief.[10][15]

Done this way, results hold up. In a London follow-up of 103 patients, satisfactory relief rose from 12% before the diet to 61% after restriction and was still 57% at long-term follow-up, when most people were on a loosened version; their diets were judged nutritionally adequate, though they found them dearer and harder to manage socially.[17] A 2025 review of five studies running six months or more found symptom benefits persisted.[18]

It is not a weight-loss diet

No trial has tested the low-FODMAP diet for weight loss, and none of the IBS trials were built to measure it. Some people lose a little anyway. In a 12-week study of 30 people with IBS, average weight fell from 78.4 to 76.6 kg;[22] in another 12-week study, BMI dipped slightly, mainly among those starting above 25.[23] Neither had a control group. In a US trial, people ate fewer calories and fewer meals on both the low-FODMAP diet and the comparison diet, which points to eating less in general rather than anything special about FODMAPs.[25]

The first of those studies also found that blood levels of the body’s own GLP‑1 hormone rose after 12 weeks on the diet.[22] It is one uncontrolled study of 30 people; the authors say the mechanism is unknown, and the rise did not track the weight change. It says nothing about appetite or weight, and it is not a substitute for a drug.

Does it help GLP-1 bloating, gas or diarrhea?

Nobody has tested it. No published trial has put people taking semaglutide or tirzepatide on a low-FODMAP diet, and none is registered on ClinicalTrials.gov. A 2026 review of 16 randomized trials of diet alongside these drugs found that stomach symptoms occurred despite the dietary advice given, and that evidence on the best nutritional approach is still limited.[21] That review is unpacked in the diet advice nobody has tested.

The Wegovy and Zepbound labels list these side effects by rate against placebo.[19][20]

Gut side effects in the weight-loss trials, percent of people. Zepbound figures are for the 5, 10 and 15 mg doses.
Side effectWegovyIts placeboZepboundIts placebo
Diarrhea30%16%19–23%8%
Abdominal distension7%5%3–4%2%
Flatulence6%4%3–4%2%
Burping (eructation)7%under 1%4–5%1%

What follows is reasoning, not evidence. Both labels say the drugs delay gastric emptying,[19][20] which is the usual explanation for fullness, nausea and burping. FODMAPs act lower down, in the small bowel and colon.[4] So the diet has no obvious reason to help burping or nausea, which is covered in burping, reflux and gas on a GLP-1. Wind and bloating from colonic fermentation are where it could plausibly help, and where its IBS record is strongest.[1] For diarrhea the case is weaker: in IBS no diet reliably changed bowel habit,[1] and why these drugs cause diarrhea is itself not understood (see GLP-1 diarrhea: what helps).

For constipation, the most lasting GLP‑1 side effect, the diet could make things worse. Wholegrain bread, beans and lentils are among the first foods it removes. In a Monash trial in people with IBS, some participants had slow colonic transit on a low-FODMAP diet providing 23 g of fiber a day. Adding fiber raised stool output by about half, and a sugarcane fiber corrected the slow transit, without weakening the symptom response.[26] The constipation guide sets out what the evidence supports.

Why the risks are bigger on a GLP-1

In IBS trials the diet is short and run by specialist dietitians, and on those terms it is mostly safe.[17][23] The concern on a GLP‑1 is that its costs land on the same places the drug already presses.

  • Fiber. Only 5% of 130 people with IBS met a 30 g fiber target before any diet, and overall diet quality fell after four weeks of low-FODMAP advice compared with a usual diet.[24] Appetite suppression already lowers fiber intake. Our fiber calculator gives a target; oats, potatoes, carrots, kiwifruit, oranges and pumpkin seeds are low-FODMAP sources.[11]
  • Calories and nutrients. In the US trial, both diets cut calories and meals, and fewer people on low FODMAP met the reference intakes for thiamin and iron after four weeks.[25] Adding a restrictive diet to a drug that already suppresses appetite raises the odds of eating too little on a GLP-1.
  • Gut bacteria. Across nine trials, the diet consistently lowered Bifidobacteria, one of the groups fed by FODMAPs, with no clear effect on overall diversity.[27] What GLP‑1 drugs do to the microbiome is itself unsettled; see GLP-1 drugs and the gut microbiome. Nobody has studied the two together.
  • Disordered eating. The AGA lists people with an eating disorder, people at risk of malnutrition and people facing food insecurity as poor candidates for restrictive diets, and calls routine screening for disordered eating critical.[10] Gut symptoms and eating disorders overlap: among outpatients being treated for an eating disorder, 39% met criteria for a disorder of gut-brain interaction such as IBS.[28] Clinicians also warn that the line between sensible food avoidance and a disorder is hard to draw in people with gut conditions.[29] For how that risk meets appetite-suppressing drugs, see GLP-1 drugs and eating disorders.

If you want to try it on a GLP-1

  1. Check the symptoms are ordinary first. Gut symptoms are common in the early months on a GLP‑1, and how long side effects last covers the usual pattern. Severe or persistent belly pain, vomiting that will not stop, or blood in the stool are not a diet problem.
  2. Know which problem you are treating. The evidence is for IBS. If you had IBS before the drug, a time-limited low-FODMAP trial is guideline-backed.[9][10] If the symptoms began with the drug, you are experimenting without data.
  3. Use a dietitian if you can. The diet was designed to be taught by a dietitian trained in it, and the AGA recommends a referral.[3][10]
  4. Keep it short and reintroduce. Two to six weeks of restriction, then structured testing. Stop if nothing improves.[10][15]
  5. Protect protein and fiber. Lean on eggs, fish, poultry, firm tofu and lactose-free dairy for protein, and on oats, potatoes and low-FODMAP fruit for fiber. The AGA counts soluble fiber as an effective IBS treatment in its own right.[10]
  6. Do not use it to lose weight. It was not designed for that, and on top of a GLP‑1 it adds restriction to restriction.
Diet changes are for ordinary bloating, wind and loose stools. Severe or persistent abdominal pain, pain spreading to the back, repeated vomiting, black or bloody stools, or being unable to pass gas or stool need medical care, not a food list. GLP-1 stomach pain: when to worry sets out the patterns the labels single out.

Frequently Asked Questions

It is a three-step elimination diet for irritable bowel syndrome. You cut foods high in fermentable short-chain carbohydrates, such as wheat, onion, garlic, beans, milk, apples and sugar-free sweeteners, for two to six weeks; then reintroduce each FODMAP group to find your triggers; then settle on a personal diet that limits only those. It was developed at Monash University in Australia.
For IBS, yes, in most trials. A 2025 analysis of 24 randomized trials found it cut the chance that symptoms failed to improve by about half compared with a usual diet, and it was the only repeatedly tested diet that beat a usual diet for bloating. Head to head against ordinary IBS diet advice, the difference was smaller and often not significant.
Nobody knows. No trial has tested it in people taking semaglutide or tirzepatide. It might ease gas and bloating that come from fermentation in the colon, but it is unlikely to help burping or nausea, which relate to slowed stomach emptying, and its fiber cuts could worsen constipation.
No. It was designed for IBS and no trial has tested it for weight loss. Small uncontrolled studies saw weight fall by a kilogram or two over 12 weeks, which is consistent with eating less overall. One study found the body's own GLP-1 hormone rose slightly on the diet, but that is not comparable to taking a GLP-1 drug.
Plain meat, poultry, fish, eggs, firm tofu and tempeh; rice, oats, quinoa and sourdough spelt bread; carrots, cucumber, lettuce, potatoes, green beans and eggplant; oranges, kiwifruit, pineapple and blueberries; lactose-free milk, hard cheeses and butter; peanuts, walnuts and pumpkin seeds. Portion size changes some ratings.
Gastroenterology guidance says people with an eating disorder, people at risk of malnutrition and people facing food insecurity are poor candidates. On a GLP-1, where appetite is already low, the risk of eating too little and too little fiber is higher. Anyone with warning signs such as bleeding or severe pain should be assessed first.

References

  1. 1.Cuffe MS, Staudacher HM, Aziz I, et al. Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis The Lancet Gastroenterology & Hepatology. 2025. PMID: 40258374.
  2. 2.Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis Gut. 2022. PMID: 34376515.
  3. 3.Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach Journal of Gastroenterology and Hepatology. 2010. PMID: 20136989.
  4. 4.Murray K, Wilkinson-Smith V, Hoad C, et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI American Journal of Gastroenterology. 2014. PMID: 24247211.
  5. 5.Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome Journal of Gastroenterology and Hepatology. 2010. PMID: 20659225.
  6. 6.Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome Gastroenterology. 2014. PMID: 24076059.
  7. 7.Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial Gastroenterology. 2015. PMID: 26255043.
  8. 8.Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D American Journal of Gastroenterology. 2016. PMID: 27725652.
  9. 9.Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome American Journal of Gastroenterology. 2021. PMID: 33315591.
  10. 10.Chey WD, Hashash JG, Manning L, Chang L. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review Gastroenterology. 2022. PMID: 35337654.
  11. 11.Monash University High and low FODMAP foods Monash FODMAP, Monash University. 2026. https://www.monashfodmap.com/about-fodmap-and-ibs/high-and-low-fodmap-foods/
  12. 12.National Institute of Diabetes and Digestive and Kidney Diseases Eating, Diet, & Nutrition for Irritable Bowel Syndrome NIDDK, National Institutes of Health. 2017. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/eating-diet-nutrition
  13. 13.Muir JG, Shepherd SJ, Rosella O, et al. Fructan and free fructose content of common Australian vegetables and fruit Journal of Agricultural and Food Chemistry. 2007. PMID: 17625872.
  14. 14.Biesiekierski JR, Rosella O, Rose R, et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals Journal of Human Nutrition and Dietetics. 2011. PMID: 21332832.
  15. 15.Monash University Starting the FODMAP diet: what to expect from the 3-step FODMAP diet Monash FODMAP, Monash University. 2026. https://www.monashfodmap.com/ibs-central/i-have-ibs/starting-the-low-fodmap-diet/
  16. 16.Eswaran S, Jencks KJ, Singh P, et al. All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome Clinical Gastroenterology and Hepatology. 2025. PMID: 38729390.
  17. 17.O'Keeffe M, Jansen C, Martin L, et al. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome Neurogastroenterology and Motility. 2018. PMID: 28707437.
  18. 18.Pouladi A, Arabpour E, Bahrami O, et al. Impacts of the Long-Term Low-FODMAP Diet in Patients With Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis Journal of Human Nutrition and Dietetics. 2025. PMID: 40735813.
  19. 19.Novo Nordisk WEGOVY (semaglutide) injection and tablets — prescribing information (sections 6.1, 7.2) DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  20. 20.Eli Lilly and Company ZEPBOUND (tirzepatide) injection — prescribing information (sections 6.1, 7.2) DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  21. 21.de Paulo RS, Bonifácio DB, de Carvalho MHL, Bressan J. Dietary Strategies and Nutritional Management in Patients Receiving GLP-1 and Dual GIP/GLP-1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials Diabetes, Obesity and Metabolism. 2026. PMID: 42037117.
  22. 22.Khan U, Brønstad I, Hillestad EMR, et al. Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients Frontiers in Nutrition. 2025. PMID: 40880735.
  23. 23.Hillestad EMR, Steinsvik EK, Teige ES, et al. Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome Neurogastroenterology and Motility. 2024. PMID: 38689453.
  24. 24.Staudacher HM, Ralph FSE, Irving PM, Whelan K, Lomer MCE. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet Journal of the Academy of Nutrition and Dietetics. 2020. PMID: 31029650.
  25. 25.Eswaran S, Dolan RD, Ball SC, Jackson K, Chey W. The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea Journal of the Academy of Nutrition and Dietetics. 2020. PMID: 31103370.
  26. 26.So D, Yao CK, Ardalan ZS, et al. Supplementing Dietary Fibers With a Low FODMAP Diet in Irritable Bowel Syndrome: A Randomized Controlled Crossover Trial Clinical Gastroenterology and Hepatology. 2022. PMID: 34929392.
  27. 27.So D, Loughman A, Staudacher HM. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis American Journal of Clinical Nutrition. 2022. PMID: 35728042.
  28. 28.Murray HB, Kuo B, Eddy KT, et al. Disorders of gut-brain interaction common among outpatients with eating disorders including avoidant/restrictive food intake disorder International Journal of Eating Disorders. 2021. PMID: 33244769.
  29. 29.Scarlata K, Zickgraf HF, Satherley RM, et al. A Call to Action: Unraveling the Nuance of Adapted Eating Behaviors in Individuals With Gastrointestinal Conditions Clinical Gastroenterology and Hepatology. 2025. PMID: 39681226.

Low-Calorie Snacks: What the Evidence Says, and What Changes on a GLP-1

Snacking is weight-neutral in randomized trials; what the snack is made of is not. Energy density, protein snacks and nuts, then why on Ozempic, Wegovy, Mounjaro or Zepbound the better snack packs the most protein into each calorie, with USDA figures.

10 min read

GLP-1 Bowel Obstruction and Ileus: Label Warning and Evidence Review

Ileus and intestinal obstruction are listed on the Ozempic, Wegovy, Mounjaro and Zepbound labels as postmarketing reports with no rate. What the 2023 JAMA signal really showed, what larger cohorts and the SELECT trial found, the warning signs, and where the lawsuits stand.

11 min read

GLP-1 Booster Supplements by Brand: What Is Inside and What Was Tested

What Bioma, Lemme, Inno Shred, HUM Flatter Me Fiber, ColonBroom, Supergut, Pendulum and Nature Made put in their GLP-1 supplements, whether any product was tested in a published trial, and what the evidence shows for each ingredient.

10 min read

Coffee on Ozempic, Wegovy or Mounjaro: What the Labels and Studies Say

You can drink coffee on Ozempic, Wegovy, Mounjaro or Zepbound; no label mentions it. Semaglutide tablets are the exception: a small glass of water alone, and coffee held for half an hour. What coffee does to reflux, heart rate, hydration and blood sugar on a GLP-1.

11 min read

Intermittent Fasting on a GLP-1: What Has Been Tested and What Has Not

No trial has added intermittent fasting or a 16:8 eating window to semaglutide or tirzepatide. What the fasting trials show on their own, and the risks that matter on a GLP-1: protein, low blood sugar, fluids, the oral tablet's morning rule and gallstones.

10 min read

Antidepressants and a GLP-1: Ozempic, Wellbutrin, Lexapro and What the Labels Say

No GLP-1 label names an antidepressant as an interaction, and people on antidepressants lost as much weight on semaglutide as everyone else. The real overlaps: stacked nausea, slowed absorption of tablets, and two bupropion rules.

11 min read

Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.4

MyDrHank

An oral route if you will not self-inject

6.6

MEDGm

Compounded semaglutide with every plan price published and the partner pharmacies named

6.6

HumeCare+

An oral route if you will not self-inject

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →